 The purpose of this study is to evaluate the long-term efficacy, tolerance and compliance of ORM Narval Mandibular Repositioning Device MRD as a second-line treatment for patients with severe Obstructive Sleep Apnea Hypopnea OSAH syndrome who refuse or are intolerant to Continuous Positive Airway Pressure CPAP treatment. 